How can cultural intelligence be the catalyst that perpetuates health equity?
-
Register
- User - $27.50
Cultivating a culture of diversity, equity, and inclusion (DEI) is not only the professional, ethical, legal, and moral responsibility of healthcare personnel, it is the cornerstone to justness in healthcare. The Institute of Medicine’s (IOM) landmark report, Unequal Treatment, purports that because of provider bias and stereotypes, racial and ethnic minorities receive suboptimal healthcare and subsequently experience health disparities (IOM, 2003). Twenty years later, the same holds true. The Centers for Disease Control and Prevention (CDC) describes the profound negative consequences of bias on the health and well-being of historically marginalized populations (CDC.gov, 2023). Bias contributes to health disparities among marginalized populations. Integration of DEI teaching strategies into learning experiences is critical to eliminating health-related consequences of bias and discrimination. Healthcare providers must analyze and synthesize the full breadth and depth of the impact of bias and discrimination on health outcomes.
During this education session, learners will be engaged through expert and dynamic presentation with Dr. Angela Richard-Eaglin, DNP, MSN, FNP-BC, CNE, FAANP, CDE. This education will appraise diversity, equity, inclusion and belonging using the cultural intelligence framework, analyze the impact of bias on advancing health equity and apply CQ strategies to mitigate bias-influenced outcomes.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 0 are Pharmacology
Expiration Date: June 30, 2025
$27.50
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
• Critically appraise diversity, equity, inclusion, and belonging using the cultural intelligence framework.
• Analyze the impact of bias on advancing health equity.
• Apply CQ strategies to mitigating bias-influenced outcomes.
Angela Richard-Eaglin, DNP, MSN, FNP-BC, FAANP, CDE
Dr. Angela Richard-Eaglin, DNP, MSN, FNP-BC, CNE, FAANP, CDE® is the Associate Dean for Equity and an Associate Clinical Professor at Yale School of Nursing. She is a board-certified family nurse practitioner and a champion for expanding diversity and inspiring cultural intelligence (CQ) and endorsing the humanitarian ethos within healthcare organizations and health professions education programs to influence translation to clinical practice. Her nursing career spans nearly 30 years, all of which has been dedicated to advancing equity among vulnerable, underrepresented, marginalized, stigmatized, and financially disadvantaged populations. She has experience teaching in Baccalaureate pre-licensure programs and MSN Programs, and she also has extensive leadership and clinical practice experience. Her clinical experience includes primary care, Veterans health, Women’s health, urgent care, and public health.
Dr. Richard-Eaglin is a globally recognized leader and mentor for her dedication to and support of initiatives aimed at cultivating environments that authentically embrace differences and embody inclusive excellence. She serves on the Board for the National Organization of Nurse Practitioner Faculties and is the Board Lead for the Diversity Committee. She is on the Editorial Board of Nursing Economics, The Journal for Health Care Leaders. Additionally, she serves on the National League for Nursing’s Taking Aim: Addressing Structural Racism, Diversity, Equity Inclusion, Implicit Bias & Social Justice Task Force and several other advisory boards.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Angela Richard-Eaglin, DNP, MSN, FNP-BC, FAANP, CDE has disclosed no relevant financial relationship.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
